0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letters |

Use of Micronutrient Supplement for Preventing Advanced Age-Related Macular Degeneration in Japan FREE

Mariko Sasaki, MD, PhD; Hajime Shinoda, MD, PhD; Takashi Koto, MD, PhD; Atsuro Uchida, MD; Kazuo Tsubota, MD, PhD; Yoko Ozawa, MD, PhD
[+] Author Affiliations

Author Affiliations: Department of Ophthalmology (Drs Sasaki, Shinoda, Koto, Uchida, Tsubota, and Ozawa) and Laboratory of Retinal Cell Biology (Drs Sasaki and Ozawa), Keio University School of Medicine, Tokyo, Japan.


Arch Ophthalmol. 2012;130(2):254-255. doi:10.1001/archopthalmol.2011.1368.
Text Size: A A A
Published online

In accordance with the results of the Age-Related Eye Disease Study (AREDS),1 a randomized controlled trial performed in the United States, patients with age-related macular degeneration (AMD) in the United States have been instructed to take micronutrient supplements when their lesion fits the inclusion criteria.2 We conducted a survey about the patients' supplement use and the ophthalmologists' attitudes toward supplements in Japan, where the use is not based on ophthalmologists' prescription.

The questionnaire was given to patients diagnosed as having AMD at the Medical Retina Division, Department of Ophthalmology, Keio University Hospital, Tokyo, Japan, between January 8, 2010, and June 25, 2010. Another questionnaire was given to the ophthalmologists in our department. Supplements containing more than 50% of the AREDS-recommended levels of vitamin C, vitamin E, and zinc were designated AREDS-like supplements, and those that contained reduced amounts of beta carotene and included lutein were designated AREDS plus lutein supplements. This study was approved by the ethics committee of the Keio University School of Medicine.

Patient Survey

Of the 163 patients with AMD who completed our questionnaire, 159 gave valid answers (119 male, 40 female; all ethnic Japanese; age range, 50-95 years; mean age, 73.9 years). Oral supplements of any type were used by 90 participants (56.6%); 23 used an AREDS-like supplement and 35 used an AREDS plus lutein supplement. Among the 139 candidates eligible for an AREDS supplement judged by the modified AREDS classification system based on fundus findings2 (Table), 48 (34.5%) used an AREDS-related supplement under their ophthalmologists' instruction; 17 used an AREDS-like supplement and 31 used an AREDS plus lutein supplement. Ninety-one participants (65.5%) had not used a supplement (Table), of whom 61 (43.9%) had not been given any instruction.

Table Graphic Jump LocationTable. Age-Related Eye Disease Study–Related Supplement Use by 159 Participants According to Age-Related Macular Degeneration Categorya
Doctor Survey

All of the 6 retinal specialists and 11 of the 12 non–retinal-specialized ophthalmologists considered AREDS-like supplements effective. All of the retinal specialists and 10 non–retinal-specialized ophthalmologists instructed their patients based on AREDS. However, 5 retinal specialists and 3 of the others included some additional information.

Overall, 56.6% of the participants in this study were taking supplements, which is lower than the proportion reported in the United States (93%).2

Surprisingly, all of the candidates who used the supplements were instructed to do so by ophthalmologists, suggesting that the patients' main source of information about supplements was their ophthalmologists. In this study, only 34.5% of the candidates used AREDS-related supplements, which is far lower than in the previous report in the United States (67%). This was in contrast to the high level of adherence among the candidates (48 of 78 participants [61.5%]; no significant difference according to age or sex). It should be noted that the instruction rate of the ophthalmologists was more critical than the adherence rate of the patients for taking supplements. Interestingly, AREDS plus lutein supplements were used more often than AREDS-like supplements in this study, in contrast to a US-based study.2 A recent survey in a Japanese cohort reporting the protective association of the serum levels of carotenoids with AMD3 and studies in animal models showing the tissue-protecting effects of lutein as a blue-light filter and antioxidant4,5 may have promoted the use of AREDS plus lutein supplements.

The ophthalmologists did not always recommend supplements in accordance with AREDS. Some ophthalmologists were not completely confident that the AREDS results are applicable to Japanese or other Asian patients with AMD because of the differences in the clinical features of Asian and white patients with AMD.2,6

The increased incidence of AMD and the resulting vision loss are now serious issues. Preventive therapy is important for both patients' personal health and their continued contributions to society. Reliable evidence based on a randomized controlled trial is still needed for ophthalmologists to appropriately instruct patients' use of supplements to prevent the progress of AMD in Japan.

Correspondence: Dr Ozawa, Department of Ophthalmology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan (ozawa@a5.keio.jp).

Financial Disclosure: None reported.

Funding/Support: Dr Ozawa has received grant support from Wakasa Seikatsu Co, Ltd, and Drs Sasaki and Ozawa have received support from the Ministry of Education, Culture, Sports, Science, and Technology in Japan.

Age-Related Eye Disease Study Research Group.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8.  Arch Ophthalmol. 2001;119(10):1417-1436
PubMed
Charkoudian LD, Gower EW, Solomon SD, Schachat AP, Bressler NM, Bressler SB. Vitamin usage patterns in the prevention of advanced age-related macular degeneration.  Ophthalmology. 2008;115(6):1032-1038, e4
PubMed   |  Link to Article
Michikawa T, Ishida S, Nishiwaki Y,  et al.  Serum antioxidants and age-related macular degeneration among older Japanese.  Asia Pac J Clin Nutr. 2009;18(1):1-7
PubMed
Sasaki M, Ozawa Y, Kurihara T,  et al.  Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes.  Diabetologia. 2010;53(5):971-979
PubMed   |  Link to Article
Sasaki M, Ozawa Y, Kurihara T,  et al.  Neuroprotective effect of an antioxidant, lutein, during retinal inflammation.  Invest Ophthalmol Vis Sci. 2009;50(3):1433-1439
PubMed   |  Link to Article
Oshima Y, Ishibashi T, Murata T, Tahara Y, Kiyohara Y, Kubota T. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study.  Br J Ophthalmol. 2001;85(10):1153-1157
PubMed   |  Link to Article

Figures

Tables

Table Graphic Jump LocationTable. Age-Related Eye Disease Study–Related Supplement Use by 159 Participants According to Age-Related Macular Degeneration Categorya

References

Age-Related Eye Disease Study Research Group.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8.  Arch Ophthalmol. 2001;119(10):1417-1436
PubMed
Charkoudian LD, Gower EW, Solomon SD, Schachat AP, Bressler NM, Bressler SB. Vitamin usage patterns in the prevention of advanced age-related macular degeneration.  Ophthalmology. 2008;115(6):1032-1038, e4
PubMed   |  Link to Article
Michikawa T, Ishida S, Nishiwaki Y,  et al.  Serum antioxidants and age-related macular degeneration among older Japanese.  Asia Pac J Clin Nutr. 2009;18(1):1-7
PubMed
Sasaki M, Ozawa Y, Kurihara T,  et al.  Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes.  Diabetologia. 2010;53(5):971-979
PubMed   |  Link to Article
Sasaki M, Ozawa Y, Kurihara T,  et al.  Neuroprotective effect of an antioxidant, lutein, during retinal inflammation.  Invest Ophthalmol Vis Sci. 2009;50(3):1433-1439
PubMed   |  Link to Article
Oshima Y, Ishibashi T, Murata T, Tahara Y, Kiyohara Y, Kubota T. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study.  Br J Ophthalmol. 2001;85(10):1153-1157
PubMed   |  Link to Article

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles